Digipath (DIGP) 0.7700 $DIGP
Global Digital Pathology Market Forecasts & Opportunities, 2020
M2 - Tue Apr 08, 9:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/98t3xh/global_digital) has announced the addition of the "Global Digital Pathology Market Forecasts & Opportunities, 2020" report to their offering. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. Automation in the conventional methods of pathology is the major driving force of this market, which has resulted in workflow efficiency, efficiency in analysis. Thus, resulting in fast and accurate results of the pathology tests. The other driving factors of this market are diagnosis that can be provided to patients in the remote regions and reduction in the cost of diagnosis. The cost includes procedure cost and the cost involved in delivery of the slides & data. The major limitation of the digital pathology market is the stringent regulations involved during the approval of digital pathology systems. The other limitation is the cost involved in the integration of DPS in the pathology labs. The challenges faced by the DP market are standardization and interoperability of the technology as the formats differ from region to region. The digital pathology market is segmented into components, end users and geography. The products market consists of the Whole slide imaging (WSI), Image analysis- informatics and Storage, communication and integrated platforms. The WSI is the highest revenue generating market among the segments; however, image analysis-informatics market is expected to have the highest growth potential. The end users market is segmented into pharmaceutical research, clinical organizations and educational institutes. The pharmaceutical research is the highest revenue generating market and is also expected to have the highest growth potential. The geography market is dominated by the North American region, which is the highest revenue generating region; however, Asian market is expected to have the highest CAGR during the analysis period. KEY MARKET SEGMENTS BY COMPONENTS - Whole slide imaging (WSI) - Image analysis- informatics - Storage, and communication and integrated platforms BY END-USERS - Pharmaceutical research - Clinical organizations - Educational institutes Key Topics Covered: - INTRODUCTION - EXECUTIVE SUMMARY - GLOBAL DIGITAL PATHOLOGY MARKET OVERVIEW - GLOBAL DIGITAL PATHOLOGY MARKET BY PRODUCTS - GLOBAL DIGITAL PATHOLOGY MARKET BY END USERS - GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY - COMPANY PROFILES - Definiens AG - Digipath Inc. - Leica Microsystems Gmbh - Ventana medical systems Inc. - Nikon Corporation - Visiopharm - Philips healthcare - Indica Labs Inc - Omnyx LLC - 3DHISTECH Ltd. Visit http://www.researchandmarkets.com/research/98...al_digital
DigiPath Next Generation Pathology Solutions
ACCESSWIRE - Thu Aug 08, 9:00AM CDT
The healthcare industry has become increasingly digitized over the past decade, with companies like Cerner Corporation (NASDAQ: CERN) and MedAssets Inc. (NASDAQ: MDAS) bringing an age-old industry up-to-speed with modern technology. But, patient medical records represent only a fraction of the digital revolution and one sector has been slower than others to modernize.
Digital Pathology Systems - Global Strategic Business Report - 2013-2018
M2 - Wed May 08, 4:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9h3l3/digital_pathology) has announced the addition of the "Digital Pathology Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 46 companies including many key and niche players such as 3DHISTECH Ltd., AccelPath, Inc., Apollo PACS, Inc., Carl Zeiss MicroImaging GmbH, Corista LLC, Definiens AG, DigiPath Inc., Flagship Biosciences, LLC, Koninklijke Philips Electronics N.V., Leica Microsystems GmbH, Aperio Technologies, Inc., MikroScan Technologies, Inc., Olympus America, Inc., Omnyx, LLC, Pixcelldata Ltd., Ventana Medical Systems, Inc., BioImagene, Inc., a
Global Digital Pathology Market Forecasts & Opportunities, 2020
M2 - Tue Apr 08, 9:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/98t3xh/global_digital) has announced the addition of the "Global Digital Pathology Market Forecasts & Opportunities, 2020" report to their offering. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. Automation in the conventional methods of pathology is the major driving force of this market, which has resulted in workflow efficiency, efficiency in analysis. Thus, resulting in fast and accurate results of the pathology tests. The other driving factors of this market are diagnosis that can be provided to patients in the remote regions and reduction in the cost of diagnosis. The cost includes procedure cost and the cost involved in delivery of the slides & data. The major limitation of the digital pathology market is the stringent regulations involved during the approval of digital pathology systems. The other limitation is the cost involved in the integration of DPS in the pathology labs. The challenges faced by the DP market are standardization and interoperability of the technology as the formats differ from region to region. The digital pathology market is segmented into components, end users and geography. The products market consists of the Whole slide imaging (WSI), Image analysis- informatics and Storage, communication and integrated platforms. The WSI is the highest revenue generating market among the segments; however, image analysis-informatics market is expected to have the highest growth potential. The end users market is segmented into pharmaceutical research, clinical organizations and educational institutes. The pharmaceutical research is the highest revenue generating market and is also expected to have the highest growth potential. The geography market is dominated by the North American region, which is the highest revenue generating region; however, Asian market is expected to have the highest CAGR during the analysis period. KEY MARKET SEGMENTS BY COMPONENTS - Whole slide imaging (WSI) - Image analysis- informatics - Storage, and communication and integrated platforms BY END-USERS - Pharmaceutical research - Clinical organizations - Educational institutes Key Topics Covered: - INTRODUCTION - EXECUTIVE SUMMARY - GLOBAL DIGITAL PATHOLOGY MARKET OVERVIEW - GLOBAL DIGITAL PATHOLOGY MARKET BY PRODUCTS - GLOBAL DIGITAL PATHOLOGY MARKET BY END USERS - GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY - COMPANY PROFILES - Definiens AG - Digipath Inc. - Leica Microsystems Gmbh - Ventana medical systems Inc. - Nikon Corporation - Visiopharm - Philips healthcare - Indica Labs Inc - Omnyx LLC - 3DHISTECH Ltd. Visit http://www.researchandmarkets.com/research/98...al_digital
DigiPath Next Generation Pathology Solutions
ACCESSWIRE - Thu Aug 08, 9:00AM CDT
The healthcare industry has become increasingly digitized over the past decade, with companies like Cerner Corporation (NASDAQ: CERN) and MedAssets Inc. (NASDAQ: MDAS) bringing an age-old industry up-to-speed with modern technology. But, patient medical records represent only a fraction of the digital revolution and one sector has been slower than others to modernize.
Digital Pathology Systems - Global Strategic Business Report - 2013-2018
M2 - Wed May 08, 4:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9h3l3/digital_pathology) has announced the addition of the "Digital Pathology Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 46 companies including many key and niche players such as 3DHISTECH Ltd., AccelPath, Inc., Apollo PACS, Inc., Carl Zeiss MicroImaging GmbH, Corista LLC, Definiens AG, DigiPath Inc., Flagship Biosciences, LLC, Koninklijke Philips Electronics N.V., Leica Microsystems GmbH, Aperio Technologies, Inc., MikroScan Technologies, Inc., Olympus America, Inc., Omnyx, LLC, Pixcelldata Ltd., Ventana Medical Systems, Inc., BioImagene, Inc., a
